Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.

Okubadejo NU, Rizig M, Ojo OO, Jonvik H, Oshinaike O, Brown E, Houlden H

Open source

DOI
10.1371/journal.pone.0207984
Published
2018
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0207984,
  title = {Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.},
  author = {Okubadejo NU and Rizig M and Ojo OO and Jonvik H and Oshinaike O and Brown E and Houlden H},
  year = {2018},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0207984},
  url = {https://doi.org/10.1371/journal.pone.0207984}
}

RIS

TY  - JOUR
TI  - Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.
AU  - Okubadejo NU
AU  - Rizig M
AU  - Ojo OO
AU  - Jonvik H
AU  - Oshinaike O
AU  - Brown E
AU  - Houlden H
PY  - 2018
JO  - PloS one
DO  - 10.1371/journal.pone.0207984
UR  - https://doi.org/10.1371/journal.pone.0207984
ER  - 

APA

NU, O., M, R., OO, O., H, J., O, O., E, B., & H, H. (2018). Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.. PloS one. https://doi.org/10.1371/journal.pone.0207984

Source records